AI-generated summary
The authors retrospectively reviewed 110 patients with dry eye disease and meibomian gland dysfunction who received intense pulsed light therapy and were followed for one year. They report improvements in symptom scores and several objective tear film and ocular surface measures, and describe the treatment as promising.
- Participants
- 110
- Who or what was studied
- Patients with dry eye disease associated with meibomian gland dysfunction receiving intense pulsed light therapy
- Limits stated in the abstract
- The study is a retrospective case series without a control group, so the observed improvements cannot be attributed to the treatment alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.